Kohler's Disease (KD) is a rare but treatable condition that affects the bones in the feet. It is most commonly seen in children between the ages of 3 and 8, but can affect adults as well. It is characterized by pain in the foot, swelling, and difficulty walking. KD is caused by a disruption in the growth of the navicular bone in the foot, which can lead to a collapse of the bone. The exact cause of KD is unknown, but it is believed to be related to trauma or infection. Treatment of KD typically includes rest, immobilization, and physical therapy. In some cases, surgery may be necessary to correct the deformity and restore normal function.
KD typically presents with pain in the foot, swelling, and difficulty walking. The pain can be sharp or dull and may be worse with activity. The affected area may be red, warm, and tender to the touch. Swelling may be localized or diffuse and may be accompanied by a decrease in range of motion. The affected area may also appear deformed or bowed. In some cases, the pain may radiate to the ankle or lower leg.
KD is diagnosed through a physical examination and imaging tests. X-rays are typically used to diagnose KD and can show a collapse of the navicular bone. Other imaging tests such as an MRI or CT scan may be used to further evaluate the extent of the condition. The doctor may also order blood tests to rule out other conditions that may be causing the symptoms.
The treatment of KD typically includes rest, immobilization, and physical therapy. Rest is important to allow the affected area to heal. Immobilization may be necessary to prevent further damage to the bone. Physical therapy can help to improve range of motion and strength in the foot. In some cases, surgery may be necessary to correct the deformity and restore normal function.
KD is a rare condition and there is no known way to prevent it. However, there are some steps that can be taken to reduce the risk of developing the condition. Wearing properly fitting shoes with good arch support can help to reduce the risk of trauma or infection to the foot. It is also important to avoid activities that may put unnecessary stress on the foot, such as running or jumping.
Kohler's Disease is a rare but treatable condition that affects the bones in the feet. It is most commonly seen in children between the ages of 3 and 8, but can affect adults as well. Symptoms of KD include pain, swelling, and difficulty walking. Diagnosis is typically made through a physical examination and imaging tests. Treatment typically includes rest, immobilization, and physical therapy. In some cases, surgery may be necessary to correct the deformity and restore normal function. While there is no known way to prevent KD, wearing properly fitting shoes with good arch support and avoiding activities that may put unnecessary stress on the foot can help to reduce the risk of developing the condition.
1.
Le cancer et le COVID ont conduit le patient à une double transplantation de poumon.
2.
Effective for localizing small, non-palpable breast lesions is ultrasound-guided localization with magnetic seeds.
3.
Long-term study links chronic conditions in midlife to higher cancer risk and mortality
4.
Subcutaneous Cancer Immunotherapies Provide New Options for Physicians and Patients
5.
When does a melanoma metastasize? Implications for management
1.
Unlocking the Mysteries of Reticulocyte Counts: A Guide to Understanding Your Blood Results
2.
The Checkpoint Architect: Unraveling the Mechanisms of PD-L1 Regulation for the Next Generation of Small-Molecule Therapies
3.
Screening Efficacy, Molecular Precision, and Therapeutic Revolutions in Lung Cancer 2025
4.
Genetic Testing in Cancer Prevention: BRCA Mutations and Lynch Syndrome Unlocked
5.
Transforming Cancer Care: CAR T-Cell Therapy for Relapsed/Refractory NHL and ALL
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part II
2.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)
3.
An In-Depth Look At The Signs And Symptoms Of Lymphoma
4.
Post Progression Approaches After First-line Third-Generaion ALK Inhibitors
5.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part IV
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation